Pneumologie 2008

Literatur

• 1 Aaron S D, Vandernheen K L, Fergusson D. et al . Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease.  Ann Intern Med. 2007;  146 545-555
• 2 Badesch D, Abman S H, Simonneau G, Rubin L J, McLaughlin V. Medical therapy for pulmonary arterial hypertension: update ACCP evidence-based clincial practice guidelines.  Chest. 2007;  131 1917-1928
• 3 Bouros D, Antoniou K M, Tzouvelekis A, Siafakas N M. Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis.  Expert Opin Biol Ther. 2006;  6 1051-1060
• 4 Calverley P MA, Anderson J A, Celli B R. et al . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.  N Engl J Med. 2007;  356 775-789
• 5 Chanez P, Burge S, Dahl J, Creemers J, Lamarca R, Garcia Gil E. Once-daily administration of aclidinium bromide, a novel, long-acting anticholinergic: a phase II, dose-finding study (abst.).  Am J Respir Crit Care Med. 2008;  177 A349
• 6 Check E. After decades of drought, new drug possibilities flood TB pipeline.  Natur Med. 2007;  13 266
• 7 Cox G, Miller D, McWilliams A, Fitzgerald J M, Lam S. Bronchial thermoplasty for asthma.  Am J Respir Crit Care Med. 2006;  173 965-969
• 8 Cox G, Thomson N C, Rubin A S. et al . Asthma control during the year after bronchial thermoplasty.  N Engl J Med. 2007;  356 1327-1337
• 9 Eberhardt R, Anantham D, Ernst A, Feller-Kopman D, Herth F. Multimodality bronchoscopy diagnosis of peripheral lung lesions: a randomized controlled trial.  Am J Respir Crit Care Med. 2007;  176 36-41
• 10 Kardos P, Wencker M, Glaab T, Vogelmeier C. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2007;  175 144-149
• 11 Make B J, Kanniess F, Bateman E D, Linberg S E. Efficacy of 3 different doses of carmoterol, a long-acting beta2-agonist in patients with COPD (abst.).  Am J Respir Crit Care Med. 2008;  177 A961
• 12 Migliori G B, Loddenkemper R, Blasi F, Raviglione M C. 125 years after Robert Koch’s discovery of the tubercle bacillus: the new XDR-TB threat. Is „science” enough to tackle the epidemic?.  Eur Respir J. 2007;  29 423-427
• 13 Miyagawa K. Clinical relevance of the homologous recombination machinery in cancer therapy.  Cancer Sci. 2008;  99 187-194
• 14 Neninger Venageras E, Torre de la A, Osorio Rodriguez M. et al . Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer.  J Clin Oncol. 2008;  26 1452-1458
• 15 Noord van J A, Smeets J J, Drenth B M, Pivovarova A, Hamilton A L, Cornelissen P JG. Single dosis of BI 1744 CL, a novel long-acting beta2-agonist, are effective for up to 24 hrs in COPD (abst.).  Am J Respir Crit Care Med. 2008;  177 A961
• 16 Rabe K F, Hurd S S, Anzueto A. et al . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD Executive Summary.  Am J Respir Crit Care Med. 2007;  176 532-555
• 17 Raviglione M C, Smith I M. XDR tuberculosis - implications for global public health.  N Engl J Med. 2007;  356 656-659
• 18 Shaw D E, Berry M A, Thomas M. et al . The use of exhaled nitric oxide to guide asthma management.  Am J Respir Crit Care Med. 2007;  176 231-237
• 19 Smith A D, Cowan J O, Brasset K P, Herbison G P, Taylor D R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.  N Engl J Med. 2005;  352 2163-2173
• 20 Tashkin D P. COPD-treatment with formoterol+ tiotropium provides a greater improvement in lung function than treatment with tiotropium alone regardless of concomitant ICS (abst.).  Am J Respir Crit Care Med. 2008;  177 A961
• 21 Tashkin D P, Celli B R, Decramer M. et al . Bronchodilator responsiveness in patients with COPD.  Eur Respir J. 2008;  31 695-696
• 22 Vier H, Schaberg T, Gillissen A. XDR (extensive resistance) -Tuberkulose.  Pneumologie. 2007;  61 606-609
• 23 Vogelmeier C, Buhl R, Criee C -P. et al . Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD).  Pneumologie. 2007;  61 e1-e40
• 24 Wallace M B, Pascual J M, Hardee J N, Odell J A. Minimally invasive endoscopic staging of suspected lung cancer.  JAMA. 2008;  133 887-891
• 25 Wenzel S E, Wilbraham D, Fuller R, Burmeister E, Longphre M. Effect of in interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies.  Lancet. 2007;  370 1422-1431